生存期-话题@MedSci

#生存期#

350篇内容 | 3560人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1378010, encodeId=cdf313e801038, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=加用贝伐珠单抗可使难治性卵巢癌无进展生存期延长1倍, objectType=article, longId=6774, objectId=daab6e74a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=daab6e74a5, replyNumber=0, likeNumber=73, createdTime=2012-06-07, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=daab6e74a5, moduleTitle=加用贝伐珠单抗可使难治性卵巢癌无进展生存期延长1倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=daab6e74a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378008, encodeId=9cde13e800876, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=间歇激素治疗会缩短前列腺癌生存期, objectType=article, longId=6770, objectId=3f696e7069, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f696e7069, replyNumber=0, likeNumber=64, createdTime=2012-06-06, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f696e7069, moduleTitle=间歇激素治疗会缩短前列腺癌生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f696e7069)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378007, encodeId=226713e8007d0, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=中医药序贯治疗延长Ⅲ/Ⅳ期胃癌患者生存期优于巩固治疗, objectType=article, longId=5879, objectId=b67358e913, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b67358e913, replyNumber=0, likeNumber=70, createdTime=2012-04-29, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b67358e913, moduleTitle=中医药序贯治疗延长Ⅲ/Ⅳ期胃癌患者生存期优于巩固治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b67358e913)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378006, encodeId=86a413e800619, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JCO：凡德他尼未能提高晚期肺癌患者的总体生存期, objectType=article, longId=4306, objectId=e19e430637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e19e430637, replyNumber=0, likeNumber=88, createdTime=2012-03-14, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e19e430637, moduleTitle=JCO：凡德他尼未能提高晚期肺癌患者的总体生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e19e430637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378005, encodeId=a70513e80053e, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=直肠癌新辅助放化疗后pCR延长生存期, objectType=article, longId=4225, objectId=06644225b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06644225b6, replyNumber=0, likeNumber=79, createdTime=2012-03-08, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06644225b6, moduleTitle=直肠癌新辅助放化疗后pCR延长生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06644225b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378004, encodeId=6a3513e800450, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JNCI：5-FU联合奥沙利铂新辅助化疗能延长结肠癌患者生存期, objectType=article, longId=3922, objectId=15253922fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15253922fc, replyNumber=0, likeNumber=73, createdTime=2012-02-08, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15253922fc, moduleTitle=JNCI：5-FU联合奥沙利铂新辅助化疗能延长结肠癌患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15253922fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378003, encodeId=3ec713e800303, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JTO：Custirsen能改善晚期非小细胞肺癌患者生存期, objectType=article, longId=3751, objectId=22d53e512b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22d53e512b, replyNumber=0, likeNumber=91, createdTime=2012-01-24, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22d53e512b, moduleTitle=JTO：Custirsen能改善晚期非小细胞肺癌患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22d53e512b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378002, encodeId=a3ea13e800289, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：阿瓦斯汀仅能延长晚期卵巢癌患者无进展生存期1-4个月, objectType=article, longId=3666, objectId=597d366685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597d366685, replyNumber=0, likeNumber=69, createdTime=2012-01-08, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597d366685, moduleTitle=NEJM：阿瓦斯汀仅能延长晚期卵巢癌患者无进展生存期1-4个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597d366685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378001, encodeId=995b13e800125, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：贝伐单抗提高攻击性乳腺癌患者生存期, objectType=article, longId=3642, objectId=911c3642d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=911c3642d8, replyNumber=0, likeNumber=79, createdTime=2012-01-08, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=911c3642d8, moduleTitle=NEJM：贝伐单抗提高攻击性乳腺癌患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=911c3642d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378000, encodeId=01f913e800082, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：两种HER2抑制剂联用能显著延长乳腺癌生存期, objectType=article, longId=3452, objectId=4d983452fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d983452fd, replyNumber=0, likeNumber=73, createdTime=2011-12-11, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d983452fd, moduleTitle=NEJM：两种HER2抑制剂联用能显著延长乳腺癌生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d983452fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377999, encodeId=93be13e7999d6, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=TACE联合全身化疗或延长乳腺癌术后肝转移患者生存期, objectType=article, longId=2943, objectId=29b429436f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29b429436f, replyNumber=0, likeNumber=90, createdTime=2011-08-02, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29b429436f, moduleTitle=TACE联合全身化疗或延长乳腺癌术后肝转移患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29b429436f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存期

2020-05-29

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

加用贝伐珠单抗可使难治性卵巢癌无进展生存期延长1倍

2012-06-07

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

间歇激素治疗会缩短前列腺癌生存期

2012-06-06

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

中医药序贯治疗延长Ⅲ/Ⅳ期胃癌患者生存期优于巩固治疗

2012-04-29

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

JCO：凡德他尼未能提高晚期肺癌患者的总体生存期

2012-03-14

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

直肠癌新辅助放化疗后pCR延长生存期

2012-03-08

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

JNCI：5-FU联合奥沙利铂新辅助化疗能延长结肠癌患者生存期

2012-02-08

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

JTO：Custirsen能改善晚期非小细胞肺癌患者生存期

2012-01-24

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

NEJM：阿瓦斯汀仅能延长晚期卵巢癌患者无进展生存期1-4个月

2012-01-08

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

NEJM：贝伐单抗提高攻击性乳腺癌患者生存期

2012-01-08

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

NEJM：两种HER2抑制剂联用能显著延长乳腺癌生存期

2011-12-11

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

TACE联合全身化疗或延长乳腺癌术后肝转移患者生存期

2011-08-02

科室
- - 订阅+
  - 更多科室
工具
服务